Key thought leaders on leading controversies at #BrainMets symposium 3/7/24: *surveillance, *treatment sequencing & *CNS-only progression - register today! virtual - complementary bit.ly/BrainMets2024 #medtwitter #btsm #lcsm #bcsm

#BrainMetastasis is a global challenge for #cancer patients - join the conversation on 3/7 w/ participants from 35+ countries: bit.ly/BrainMets2024 🧠 Registration complementary! All interested physicians/scientists/advocates welcome #MedTwitter #btsm #lcsm #bcsm OncoAlert

Join the 3/7 MSK #BrainMets Symposium for updates on key clinical trials - incl. #leptomeningeal disease, targeted + immunotherapy strategies (incl TIL) & #neurosurgery trials. Virtual & complementary 🔜 bit.ly/BrainMets2024 #MedTwitter #btsm #lcsm #bcsm OncoAlert

This Thurs 3/7 @ intl #BrainMetastasis symposium: Drs Adrienne Boire, Qing Chen, Siting Gan & Peter Siegel share innovative work transforming early detection, prevention & treatment in parenchymal + leptomeningeal CNS disease➡️ reg today (no charge)! bit.ly/BrainMets2024 #btsm

This Thurs 3/7 @ #brainmets symposium: Expanding Reach from patient to intl scale ➡️Sperduto: integrating multimodal data ➡️Li: coalescing intl trials ➡️Budhu: advancing equity ➡️Daly: local/home care delivery Reg today (free!): bit.ly/BrainMets2024 OncoAlert #btsm

All-⭐️ lineup discussing changing prognoses with #brainmetastases across cancers: this Thursday 3/7 - Drs Michael Postow, Sarah Goldberg, Rebecca Dent and Minesh Mehta. Register (complementary) at bit.ly/BrainMets2024 #btsm OncoAlert #lcsm #btsm American Brain Tumor Association #medtwitter

Join us for an important update on the latest treatments and research in #brainmetastases. Brain Metastasis Program @ MSK Neurosurgery at Memorial Sloan Kettering #MSKbrainmetsCME bit.ly/3TbNfEs

Excited for tomorrow's fantastic panel on #brainmet grail: prevention & early detection. Join for insights from 🧠B. Ellingson (advanced neuro imaging) 🧠M. Hayden Gephart (liquid biopsy) 🧠A. Zimmer (chemoprevention) Alexandra Zimmer Register (complementary) at: bit.ly/BrainMets2024

Rare? Leptomeningeal incidence is almost 10X that of glioblastoma. Yet, the number of trials available for those patients is 1/3 of that for GBM. Eye-opening slide by Dr. Priya Kumthekar from Lurie Cancer Center. #MSKBRAINMETSCME

Next time you are asked about prognosis in patients with #BrianMets make sure to use the GPA calculator to assess estimated survival. It’s even available on MDCalc.com (for GI cancers). Great talk by Dr Sperduto

Great work from Ori Barzilai Neurosurgery at Memorial Sloan Kettering and MSKCC Spine Tumor Center . This is a major advance in the management of #Spine_Tumors. Robotic Neurosurgery at MSK Speeds Recovery From Some Spinal Tumors mskcc.org/news/robotic-n…

New by Dr Kathryn Ries Tringale The Pike Lab: Small cell #lungcancer often metastasizes to the brain & has poor prognosis. This analysis of #SCLC #lcsm transcriptional factor subtypes finds differential CNS-specific outcomes & may help guide personalized care ascopubs.org/doi/full/10.12…

🧠⚡️🫁☢️New in Journal of Clinical Oncology from The Pike Lab Chad Rusthoven: The addition of up-front #radiation #SRS to CNS-penetrant #TKI ⬆️time-to-CNS progression & local control (but not OS) in pts with brain mets from #EGFR #ALK-driven #NSCLC #lungcancer. #lcsm #radonc ascopubs.org/doi/10.1200/JC…

Energizing and inspiring #snoasco24 - congrats to Hussein Tawbi, MD, PhD and Priya Kumthekar on a most successful #CNSmets meeting! Congrats also to Emanuela Ferraro on her #WinHER2 update SNO ASCO

CNS mets=increasingly the main challenge in HER2+ #breastcancer. Here we show that fully 55% of pts w/such spread suffer CNS-related mortality; even more so in the growing (+longer-surviving) population w/CNS-only disease jamanetwork.com/journals/jaman…

Congratulations to winners of The Brain Prize 2025! Professors Michelle Monje🎗️ 🟦, Stanford Medicine and HHMI Investigator, and Frank Winkler, Heidelberg University Hospital, have pioneered the field of Cancer Neuroscience. They have revealed a profound connection between cancer and

I am pleased to share that Memorial Sloan Kettering Cancer Center’s state-of-the-art cancer care  pavilion currently under construction will be named The Kenneth C. Griffin Pavilion at Memorial Sloan Kettering Cancer Center. We are deeply grateful to Ken for his extraordinary generosity and all he

Super proud of Ali Toth on excellent presentation AANS NS Tumor Section & Master's eval'ing radiomic features vs multidisciplinary consensus in predicting #CNS #melanoma post-RT recurrence vs necrosis/heme. 🚨2026 nsgy applicant alert-she will match highly! Brain Metastasis Program @ MSK

On the heels of practice-changing #DB-09 & #ASCENT-04 at #ASC025, pleased to share new review on the role of #ADCs in #brainmets, increasingly key survival determinant in pts w met cancers link.springer.com/article/10.100… #bcsm #lcsm #oncoalert Neurosurgery at Memorial Sloan Kettering MSK Department of Medicine Memorial Sloan Kettering Radiation Oncology

had the honor of presenting our study on melanoma brain metastases at #SNOASCO2025 incredibly grateful for the opportunity to present alongside so many inspiring leaders in the field! excited to keep learning & contributing in advancing care for patients Brain Metastasis Program @ MSK Nelson Moss